In connection with the implementation of the project titled “Design and development of nanoparticle-RNA-based drugs for use in anti-cancer therapy, including the construction of a nanoparticle platform for the targeted delivery of therapeutic nucleic acids” by Biotechna SA under contract no. 2022/ABM/06/ 00005-00 for co-financing of a commercial project under the Competition for the development of targeted or personalized medicine based on medicinal products derived from nucleic acids and small-molecule compounds, the Contracting Authority is conducting market research regarding the costs of purchasing and delivering chemical reagents.
To submit a offer, please review the detailed terms of the notice contained in Request for Quotation No. 32/2026 and submit the completed offer form along with the product range and price list.